Outstanding Women in Business 2020: Dr. Amelia Gallitano, University of Arizona College of Medicine – Phoenix Aug. 27, 2020 Dr. Amelia Gallitano, an associate professor, basic medical sciences and psychiatry, was named to the Phoenix Business Journal's "Outstanding Women in Business" list. Phoenix Business Journal
Five Tips for Hygienic Restrooms Aug. 26, 2020 While leading health organizations such as the World Health Organization and Centers for Disease Control and Prevention recommend the use of hand dryers, experts say misinformation about this equipment remains. Kelly Reynolds, a professor and Department Chair at the Mel and Enid Zuckerman College of Public Health at the University of Arizona, offered an explanation as to the root of these misconceptions, stating that, “Consumers may only read (sensationalized) headlines which can influence public opinion toward biased or erroneous conclusions, (but) the fact is, the breadth of data available does not favor one hand drying method as being more hygienic or safer.” Facility Executive
Poison Centers In Arizona Warn Against Use Of Oleandrin For COVID-19 Aug. 26, 2020 The Arizona Poison and Drug Information Center at the University of Arizona College of Pharmacy and Banner Health's Poison and Drug Information Center in Phoenix are warning residents statewide against using inappropriate medications and botanical products such as oleandrin to prevent or treat COVID-19. KJZZ-FM (NPR) Phoenix
MJFF Awards $8.8M in Grants Supporting Wide Range of Parkinson’s Studies Aug. 26, 2020 The Michael J. Fox Foundation has awarded more than $8.8 million in wide-ranging grants to scientists aiming to better understand, diagnose and treat Parkinson's disease. One grant recipient is Dr. Lalitha Madhavan, an associate professor in the University of Arizona Department of Neurology at the College of Medicine - Tucson. She and her team are developing a human cellular system to help in the early identification and study of Parkinson’s mechanisms. Specifically, they want to develop dopamine neurons and patient-derived skin cells – called fibroblasts – for use in evaluating in clinical trials potential Parkinson's therapies and biomarkers. Parkinson's News Today
Arizona Poison Centers Warn about Avoiding Inappropriate Medications for COVID-19 Treatment: Oleandrin Aug. 25, 2020 Inappropriate medications – such as oleandrin, a derivative of oleander known to be toxic – used to prevent or treat COVID-19 could cause significant harm and no benefit, University of Arizona Health Sciences-based center and Banner Health center warn. Read more Image
UArizona Health Sciences Researcher to Study Cellular Stress Responses Common in Cancer, Aging Aug. 25, 2020 Bolstered by a $1.6 million grant, Dr. Timothy Bolger, at the University of Arizona Cancer Center, is studying how cells respond to stress and the role this process has in cancer growth and aging. Read more Image
UArizona to Study the Effects of ‘Cellular Stress’ on Cancer and Aging Aug. 25, 2020 Understanding how cells respond to stress may provide new building blocks for designing future cancer and aging treatments. Timothy Bolger, a researcher at the University of Arizona Cancer Center, received a $1.6 million grant from the National Institutes of Health to investigate how cells respond to stress and the role this process may have in cancer growth and aging. KOLD-TV (CBS) Tucson
Breast Cancer Therapy Associated with Reduced Risk of Neurodegenerative Disease in Women Aug. 24, 2020 A University of Arizona Health Sciences cohort study of more than 50,000 menopausal women showed significant decrease in Alzheimer’s disease diagnosis. Read more Image
Blood Plasma Touted as COVID-19 Breakthrough. But Does It Work? Aug. 24, 2020 The U.S. has granted emergency authorization for convalescent plasma, but experts say the science around the treatment isn't settled. University of Arizona College of Medicine – Tucson researcher and ICU medical director Christian Bime isn’t concerned about political pressure – out of confidence in the scientists embedded in the process. "I trust scientists to do the right thing," Bime said. "The stakes are too high and the consequences too dire for scientists to not follow best practice." National Geographic